Search research articles
Contact Us
Filters
Showing results (91-100 of 477) with videos related to
Page
of 48
Sort By:
Nature Reviews. Nephrology
|
September 20, 2016
Scleroderma renal crisis and renal involvement in systemic sclerosis
Thasia G Woodworth, Yossra A Suliman, Wendi Li, et al.
The Journal of Rheumatology
|
March 3, 2012
Epidemiology of systemic sclerosis in a large US managed care population
Daniel E Furst, Ancilla W Fernandes, Serban R Iorga, et al.
RMD Open
|
November 5, 2015
Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis
Michael Nurmohamed, Yanjun Bao, James Signorovitch, et al.
Muscle & Nerve
|
April 14, 2012
Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan
Daniel E Furst, Anthony A Amato, Şerban R Iorga, et al.
Journal of Scleroderma and Related Disorders
|
April 7, 2022
Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patients
Yossra Atef Suliman, Suzanne Kafaja, Mohamed Alemam, et al.
Clinical Immunology (Orlando, Fla.)
|
July 18, 2006
Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosis
Jan Storek, Richard A Nash, Peter A McSweeney, et al.
Annals of the Rheumatic Diseases
|
January 26, 2013
Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis
Jérôme Avouac, Dörte Huscher, Daniel E Furst, et al.
Annals of the Rheumatic Diseases
|
January 20, 2007
The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis
László Czirják, Zoltán Nagy, Martin Aringer, et al.
Rheumatology and Therapy
|
November 23, 2019
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data
Paul Emery, Daniel E Furst, Petra Kirchner, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
April 30, 2008
Oral cyclophosphamide for active scleroderma lung disease: a decision analysis
Dinesh Khanna, Daniel E Furst, Philip J Clements, et al.
Page
of 48
Search research articles
Search
Showing results (91-100 of 477) with videos related to
Sort By:
Page
of 48
Nature Reviews. Nephrology
|
September 20, 2016
Scleroderma renal crisis and renal involvement in systemic sclerosis
Thasia G Woodworth, Yossra A Suliman, Wendi Li, et al.
The Journal of Rheumatology
|
March 3, 2012
Epidemiology of systemic sclerosis in a large US managed care population
Daniel E Furst, Ancilla W Fernandes, Serban R Iorga, et al.
RMD Open
|
November 5, 2015
Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis
Michael Nurmohamed, Yanjun Bao, James Signorovitch, et al.
Muscle & Nerve
|
April 14, 2012
Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan
Daniel E Furst, Anthony A Amato, Şerban R Iorga, et al.
Journal of Scleroderma and Related Disorders
|
April 7, 2022
Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patients
Yossra Atef Suliman, Suzanne Kafaja, Mohamed Alemam, et al.
Clinical Immunology (Orlando, Fla.)
|
July 18, 2006
Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosis
Jan Storek, Richard A Nash, Peter A McSweeney, et al.
Annals of the Rheumatic Diseases
|
January 26, 2013
Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis
Jérôme Avouac, Dörte Huscher, Daniel E Furst, et al.
Annals of the Rheumatic Diseases
|
January 20, 2007
The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis
László Czirják, Zoltán Nagy, Martin Aringer, et al.
Rheumatology and Therapy
|
November 23, 2019
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data
Paul Emery, Daniel E Furst, Petra Kirchner, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
April 30, 2008
Oral cyclophosphamide for active scleroderma lung disease: a decision analysis
Dinesh Khanna, Daniel E Furst, Philip J Clements, et al.
Page
of 48